ID: ALA5276366

Max Phase: Preclinical

Molecular Formula: C52H58N8O9S

Molecular Weight: 971.15

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCC(=O)NCCCC(=O)Nc2cccc(Cc3c(C)c4ccc(Oc5ncccn5)cc4oc3=O)c2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C52H58N8O9S/c1-30-39-18-17-38(68-51-54-22-9-23-55-51)27-42(39)69-50(67)40(30)25-33-10-7-11-36(24-33)58-44(63)12-8-21-53-43(62)19-20-45(64)59-47(52(4,5)6)49(66)60-28-37(61)26-41(60)48(65)57-31(2)34-13-15-35(16-14-34)46-32(3)56-29-70-46/h7,9-11,13-18,22-24,27,29,31,37,41,47,61H,8,12,19-21,25-26,28H2,1-6H3,(H,53,62)(H,57,65)(H,58,63)(H,59,64)/t31-,37+,41-,47+/m0/s1

Standard InChI Key:  XFWUEFJLWRQESX-GANDGMNLSA-N

Associated Targets(Human)

VHL-MAP2K1/MAP2K2 64 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A-375 9258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 971.15Molecular Weight (Monoisotopic): 970.4047AlogP: 6.69#Rotatable Bonds: 18
Polar Surface Area: 235.05Molecular Species: NEUTRALHBA: 13HBD: 5
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.47CX Basic pKa: 2.65CX LogP: 4.10CX LogD: 4.10
Aromatic Rings: 6Heavy Atoms: 70QED Weighted: 0.04Np Likeness Score: -0.72

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source